Press Releases

FDA Feedback on SPA Estelle®: a New Step Closer to the Launch of Estelle® Phase III Pivotal Clinical Studies
5 April 2016
EN FR

Topline Results of Food Effect Study of the Product Candidate Estelle®, the New Combined Oral Contraceptive Composed of 15 mg of Estetrol (E4) and 3 mg of Drospirenone (DRSP)
1 April 2016
EN FR

Update on Zoreline® Projects Including Last Interim Results for the Pharmacodynamics Study of the 3-­‐Month Implant
31 March 2016
EN FR

Formulation Development of the Product Candidate Myring is Complete, Production of Clinical Batches for the Final Bioequivalence Study can Start
30 March 2016
EN FR

Already 4 European Countries Fully Approved Protocol of MIT-ES001-C301 Estelle Phase III Clinical Study
24 March 2016
EN FR

Mithra’s Tibelia® gets green light for market authorization in 14 European Countries, reinforces its CDMO ​production pipeline and demonstrates its development capabilities
10 March 2016
EN FR

Mithra Unveils its Business Plan to More Than 35 French Journalists in Presence of Roselyne Bachelot, Former France’s Health Minister
9 March 2016
EN FR

Lancering van de website Gyn&co
7 March 2016
FR NL

Press Release: Financial Results 2015
3 March 2016
EN FR

Financial Results 2015
3 March 2016
EN FR

Mithra Pharmaceuticals Announces the Appointment of an Estetrol Development Programs Director
16 February 2016
EN FR NL

Mithra Pharmaceuticals SA/NV Won PLG Business Development Award For 2015
8 February 2016
EN FR NL